References: John Hopkins University of Medicine Coronavirus Resource Center. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. https://coronavirus.jhu.edu/. Accessed October 15, 2020.
Hendren NS, Drazner MH, Bozkurt B, Cooper LT Jr. Description and proposed management of the acute COVID-19 cardiovascular syndrome. Circulation. 2020;141:1903-1914.
Shafi AM, Shaikh SA, Shirke MM, Iddawela S, Harky A. Cardiac manifestations in COVID-19 patients-a systematic review. J Card Surg. 2020;35(8):1988-2008.
Engelman DT, Lother S, George I, et al. Ramping up delivery of cardiac surgery during the COVID-19 pandemic: a guidance statement from The Society of Thoracic Surgeons COVID-19 Task Force. Ann Thorac Surg. 2020;110:712-717.
Shafi AM, Awad WI. Transcatheter aortic valve implantation versus surgical aortic valve replacement during the COVID-19 pandemic-current practice and concerns. J Card Surg. 2020;14.
Camm J, Luscher T, Maurer G, Serruys P. The ESC Textbook of Cardiovascular Medicine. Vol 2, 3rd ed. Oxford: Oxford University Press/European Society of Cardiology; 2019.
Carabello BA. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. Curr Cardiol Rep. 2011;13(3):173-174.
Mariathas M, Rawlins J, Curzen N. Transcatheter aortic valve implantation: Where are we now? Future Cardiol. 2017;13(6):551-566.
Khialani B, MacCarthy P. Transcatheter management of severe aortic stenosis during the COVID-19 pandemic. Heart. 2020;106:1183-1190.
England.nhs.uk. 2020. [online] https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/04/second-phase-of-nhs-response-to-covid-19-letter-to-chief-execs-29-april-2020.pdf. Accessed October 12, 2020.
Everett RJ, Clavel MA, Pibarot P, et al. Timing of intervention in aortic stenosis: a review of current and future strategies. Heart. 2017:104.
Seshadri M, Ahamed J, Laurence J. Intervention in COVID-19 linked hypercoaguable states characterized by circuit thrombosis utilizing a direct thrombin inhibitor. Thrombosis Update. 2020;1:100009.
Tanguturi V, Lindman B, Pibarot P, et al. Managing Severe Aortic Stenosis in the COVID-19 Era. JACC: Cardiovasc Interv. 2020;13(16):1937-1944.
Baumgartner H, Falk V, Bax JJ, et al. ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739-2791.
Czarny MJ, Resar JR. Diagnosis and management of valvular aortic stenosis. Clin Med Insights Cardiol. 2014;8(suppl 1):15-24. https://doi.org/10.4137/CMC.S15716.
Iung B. Interface between valve disease and ischaemic heart disease. Heart. 2000;84:347-352.
Thalji NM, Suri RM, Daly RC, et al. The prognostic impact of concomitant coronary artery bypass grafting during aortic valve surgery: implications for revascularization in the transcatheter era. J Thorac Cardiovasc Surg. 2015;149:451-460.
Biasco L, Ferrari E, Pedrazzini G, et al. Access sites for TAVI: patient selection criteria, technical aspects, and outcomes. Front Cardiovasc Med. 2018;5:88.
Duncan A, Ludman P, Banya W, et al. Long-term outcomes after transcatheter aortic valve replacement in high-risk patients with severe aortic stenosis: the UK Transcatheter Aortic Valve Implantation Registry. JACC: Cardiovasc Interv. 2015;8(5):645-653.
Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609-1620.
Falk V, Baumgartner H, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg. 2017;52(4):616-664.
Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380(18):1706-1715.
Kolte D, Vlahakes GJ, Palacios IF, et al. Transcatheter versus surgical aortic valve replacement in low-risk patients. J Am Coll Cardiol. 2019;74(12):1532-1540.
No Comments.